MRIs and ICDs can mix, at least if MR imaging is with a 1.5 Tesla machine and the implantable cardioverter-defibrillator system is the one tested in a late-breaking clinical trial presented May 14 at the Heart Rhythm Society’s scientific session in Boston.
The use of myocardial perfusion imaging (MPI) has spiked over the past four decades and along with it individual patient dose. A comprehensive effort to reduce that dose could reduce unnecessary procedures and reduce the risk of downstream cancers, according to a meta-analysis published in the April issue of the Journal of Nuclear Medicine.
High-grade astrocytoma is a particularly aggressive form of glioma. Parameters of PET imaging such as the minimal time-to-peak could help clinicians narrow in on the best line of treatment for each patient, according to a study published Dec. 23 in the Journal of Nuclear Medicine.
A quantitative PET measurement known as total lesion glycolysis could help clinicians make informed prognoses for patients with a stage of non-small lung cancer, according to a study published online Dec. 18 in the Journal of Nuclear Medicine.
The global market for nuclear imaging technology is forecasted to reach $2.2 billion in 2020, just a 3.3 percent compound annual growth rate over the $1.83 billion noted for 2013, according to a December 2014 report by GlobalData.